mo:re is a biotechnology start-up reducing the time to market for new therapies by replacing animal trials with AI-assisted cultivation of disease models from human cells. Our platform of a laboratory robot and software, enables scaling up experiments without compromising traceability and quality to bridge the gap between proof of concept and industry experiments.